If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Laura Botti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

SPARC is a new myeloid-derived suppressor cell marker licensing suppressive activities

Sangaletti, S., Talarico, G., Chiodoni, C., Cappetti, B., Botti, L., Portararo, P., Gulino, A., Consonni, F. M., Sica, A., Randon, G., Nicola, M. D., Tripodo, C. & Colombo, M. P., Jan 1 2019, In : Frontiers in Immunology. 10, JUN

Research output: Contribution to journalArticle

  • SPARC is a new myeloid-derived suppressor cell marker licensing suppressive activities

    Sangaletti, S., Talarico, G., Chiodoni, C., Cappetti, B., Botti, L., Portararo, P., Gulino, A., Consonni, F. M., Sica, A., Randon, G., Nicola, M. D., Tripodo, C. & Colombo, M. P., Jan 1 2019, In : Frontiers in Immunology. 10, JUN, 1369.

    Research output: Contribution to journalArticle

    Open Access
  • Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-beta.

    Jachetti, E., Rigoni, A., Bongiovanni, L., Arioli, I., Botti, L., Parenza, M., Cancila, V., Chiodoni, C., Festinese, F., Bellone, M., Tardanico, R., Tripodo, C. & Colombo, M. P., Feb 1 2017, In : Molecular Cancer Therapeutics. 16, 2, p. 365-375 11 p.

    Research output: Contribution to journalArticle

    Imatinib spares cKit-expressing prostate neuroendocrine tumors, whereas kills seminal vesicle epithelial-stromal tumors by targeting PDGFR-β

    Jachetti, E., Rigoni, A., Bongiovanni, L., Arioli, I., Botti, L., Parenza, M., Cancila, V., Chiodoni, C., Festinese, F., Bellone, M., Tardanico, R., Tripodo, C. & Colombo, MP., 2017, In : Molecular Cancer Therapeutics. 16, 2, p. 365-375 11 p.

    Research output: Contribution to journalArticle

  • Persistent immune stimulation exacerbates genetically driven myeloproliferative disorders via stromal remodeling

    Tripodo, C., Burocchi, A., Piccaluga, P. P., Chiodoni, C., Portararo, P., Cappetti, B., Botti, L., Gulino, A., Isidori, A., Liso, A., Visani, G., Martelli, M. P., Falini, B., Pandolfi, P. P., Colombo, M. P. & Sangaletti, S., Jul 1 2017, In : Cancer Research. 77, 13, p. 3685-3699 15 p.

    Research output: Contribution to journalArticle